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Background:  Human  respiratory  syncytial  virus  (HRSV)  is the  leading  cause  of acute  lower  respiratory
tract  infection  in  infants  and  young  children.  However,  molecular  characteristic  of  HRSV  is still  unknown
in  the  Philippines.
Objective:  To describe  the  molecular  epidemiology  of circulating  HRSV  detected  in  the  Philippines.
Study  design:  From  May  2008  to April  2012,  nasopharyngeal  swabs  were  collected  from  infants  and
children  aged  between  7 days  and  14 years  who  were  hospitalized  with  severe  pneumonia.  HRSV  was
detected  by nested  PCR  targeting  M2  gene,  and  C-terminus  of  the  G gene  was  sequenced  for  phylogenetic
analysis.
Result:  Out  of total  2150  samples,  19.3%  (n =  415)  were  positive  for HRSV,  and  65.0%  of  them  (n  = 270)  were
identiﬁed  as HRSV-A  and  35.0%  (n = 145)  as  HRSV-B.  There  were  two  major  HRSV  outbreaks:  between  June
2008 and  February  2009,  and  between  June  and  March  2012.  Majority  of  HRSV  strains  detected  during  the
former outbreak  were  HRSV-A  (97.5%,  203/208)  whereas  during  the  later  outbreak,  both  HRSV-A  (54/158,
34.2%)  and HRSV-B  (104/158,  65.8%)  were  detected.  All HRSV-A  strains  were  classiﬁed  as  genotype  NA1
and all  HRSV-B  as  genotype  BA,  which  had  60-nucleotide  duplication  in  secondary  hypervariable  region
of  the G gene.  Among  HRSV-B  positive  samples,  there  were  2  distinct  clusters  with  unique  amino  acid
changes  and  low  homology  in  compared  to other  strains  in  BA, suggesting  emergence  of new  variant  of
HRSV-B.
Conclusion:  The  study  provides  an  overview  of  the genetic  variation  in  circulating  HRSV  viruses  in  the
Philippines  along  with identiﬁcation  of  possibly  a  novel  variant  of  HRSV-B.. BackgroundAcute lower respiratory tract infection (ALRI) is a leading cause
f death in children aged less than ﬁve years worldwide, and most
Abbreviations: HRSV, human respiratory syncytial virus; HRSV-A, human respi-
atory syncytial virus subgroup A; HRSV-B, human respiratory syncytial virus
ubgroup B; ALRI, acute lower respiratory tract infection; EVRMC, Eastern Visayas
egional Medical Center; NPS, nasopharyngeal swab; IMCI, Integrated Management
f  Childhood Illness; VTM, viral transport medium; RITM, Research Institute for
ropical Medicine; cDNA, complementary DNA; N, nucleocapsid; m-PCR, multiplex
olymerase chain reaction; M-MLV  reverse transcriptase, Moloney murine leukemia
irus reverse transcriptase.
∗ Corresponding author. Tel.: +81 22 717 8211; fax: +81 22 717 8212.
E-mail address: suzukia@med.tohoku.ac.jp (A. Suzuki).
386-6532 © 2013 Elsevier B.V.  
ttp://dx.doi.org/10.1016/j.jcv.2013.01.001
Open access under CC BY-NC-ND license.© 2013 Elsevier B.V. 
of those deaths occur in developing countries.1 The role of human
respiratory syncytial virus (HRSV) in the etiology of ALRI has been
well deﬁned in developed countries2,3 as well as in developing
countries.4–7 In the Philippines, several etiological studies on ALRI
in children have been conducted, in which HRSV were detected in
7.1–18.9% of the ALRI cases.8–12 Recently, we showed that HRSV
is the second most common respiratory viral pathogen next to
rhinoviruses among the children with severe pneumonia in the
Philippines.13 However, molecular characterization of the detected
HRSV has not been yet studied.
HRSV has been divided into two  subgroups (HRSV-A and HRSV-
Open access under CC BY-NC-ND license.B) by reactivity with monoclonal antibody.14,15 The HRSV envelope
contains three transmembrane surface glycoproteins; the major
attachment protein G, the fusion protein F, and the small hydropho-
bic SH protein. G protein is mainly involved in virus attachment
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o host cells and plays major role in the immunogenicity of the
irus. Nowadays, HRSV subgroups can also be identiﬁed by genetic
nalysis.16 G gene is the most variable among HRSV genes and has
wo hypervariable regions. The analysis of this region is commonly
sed for studying the molecular epidemiology studies of HRSV.17,18
urrently, HRSV-A has 10 genotypes (GA1–GA7, SAA1, NA1, NA2)
hereas HRSV-B has 9 genotypes (SAB1–SAB4, GB1–GB4, BA) with
A having 11 branches (BA1–11).19–25
. Objectives
The objective of this prospective study was to describe the
olecular epidemiology of circulating HRSV in the Philippines for
he last four years between May  2008 and April 2012 by phyloge-
etic analysis of the secondary hypervariable region of G gene.
. Study design
.1. Patients and clinical samples
From May  2008 to April 2012, nasopharyngeal swabs (NPSs)
ere collected from infants and children aged between 7 days and
4 years who were hospitalized for severe pneumonia in Eastern
isayas Regional Medical Center (EVRMC) in Tacloban city of Leyte
sland, the Philippines.13 The patients were diagnosed as severe
neumonia according to the case deﬁnition of Integrated Manage-
ent of Childhood Illness (IMCI).26 A total of 2150 patients were
nrolled into the study. After sample collection, NPSs were stirred
n 3 ml  of viral transport medium (VTM) and transported with ice
acks to the Research Institute for Tropical Medicine (RITM) in
anila for further analysis.
.2. RNA extraction and complementary DNA synthesis
RNA was extracted from supernatant of clinical samples using
IAamp Viral RNA Mini kit (QIAGEN, Hilden, Germany). Reverse
ranscription PCR to synthesize complementary DNA (cDNA) was
erformed using Moloney murine leukemia virus (M-MLV) reverse
ranscriptase and random primers (all were from Invitrogen Carls-
ad, CA, USA).
.3. Detection of HRSV
For HRSV screening, multiplex polymerase chain reaction (m-
CR) was performed to amplify nucleocapsid (N) gene of HRSV
ogether with inﬂuenza A virus, inﬂuenza B virus, and human
etapneumovirus as previously described (Table 1).13,27 The
esults of multiplex PCR were conﬁrmed by PCR targeting M2  gene
sing Ex Taq (TaKaRa, Otsu, Japan) (Table 1).28 From January 2010,
e used PCR targeting M2  gene as an alternative screening method.
.4. Subgrouping, sequencing and phylogenetic analysis of HRSV
To determine subgroups, we performed the nested PCR tar-
eting C-terminus of the G gene, which included the secondary
ypervariable region (HRSV-A: 270 bp, HRSV-B: 330 bp)17,22
Table 1). After purifying the ampliﬁcation product using SUPRECTM
CR (TaKaRa, Otsu, Japan), nucleotide sequence was determined
y BigDye Terminator v3.1 Cycle Sequencing Kit (Applied Biosys-
ems, Foster City, CA, USA) and Genetic Analyzer 3130 (Applied
iosystems, Foster City, CA, USA).
Related sequences were searched by using the Basic Local Align-
ent Search Tool (BLAST). Phylogenetic trees based on sequences
f the second hypervariable region of G gene were generated by
he neighbor-joining method and maximum composite likelihood Virology 57 (2013) 59– 65
model with Molecular Evolutionary Genetic Analysis (MEGA) soft-
ware version 5.0.29 Since there is an insertion of 60 nucleotides in
HRSV-BA, we used both complete and pairwise deletion method
for treating the gap and conﬁrming the consistency of formulated
trees. Representative sequences of the corresponding region of
each genotype were adapted from previous studies,20–25,30,36–39
and the identical sequences were excluded from the analysis (Sup-
plemental Table 1). Homogeneity among the strains was  compared
by pairwise distances (p-distance) estimated by MEGA software
version 5.0. All sequences used in present study were deposited in
the GenBank under accession numbers: AB749604–AB749760.
Supplementary material related to this article found, in the
online version, at http://dx.doi.org/10.1016/j.jcv.2013.01.001.
4. Results
4.1. Detection and subgrouping of HRSV
From May  2008 to April 2012, 2150 NPSs were collected from
hospitalized children with severe pneumonia and 19.3% (n = 415)
were positive for HRSV. HRSV positive rates were varied yearly with
the highest rate in 2008 (33.0%, 203/615) and the lowest in 2009
(1.8%, 6/339) (Fig. 1). By subgroup speciﬁc nested PCR targeting G
gene, HRSV-positive samples were classiﬁed into HRSV-A (65.0%,
270/415) and HRSV-B (35.0%, 145/415).
During the study period, there were two major HRSV outbreaks;
one was  in between June 2008 and February in 2009 and another
one was in between June 2011 and March 2012. Majority of HRSV
strains detected in the earlier outbreak were HRSV-A (203/208,
97.5%). On the other hand, the outbreak in 2011 to 2012 was
caused by both HRSV-A (62/164, 37.8%) and HRSV-B (102/164,
62.1%) (Fig. 1). Notably, in the beginning of the second outbreak in
2011, a majority of detected HRSV was HRSV-A, but the numbers of
HRSV-B cases were increased toward the end of the outbreak. From
October 2009 to March 2010, only HRSV-A cases were detected; on
the other hand, both HRSV-A and HRSV-B were detected between
May  2010 and January 2011. It is noteworthy that increased num-
bers of total hospitalized cases with severe pneumonia coincided
with these two  HRSV outbreaks. Only sporadic cases were detected
in between October 2009 and January 2011 with slight increase in
January 2010.
4.2. Genetic characterization
The sequence of the second hypervariable region of C-terminus
of G gene was determined for 96 out of 270 (35.6%) HRSV-A pos-
itive samples and 77 out of 145 (53.1%) HRSV-B positive samples
(Supplementary Table 2).
Supplementary material related to this article found, in the
online version, at http://dx.doi.org/10.1016/j.jcv.2013.01.001.
The phylogenetic tree of G gene’s second hypervariable region
(270 nucleotides) indicated that all HRSV-A were classiﬁed as
NA124 (Fig. 2A). Based on the BLAST, the cases detected in
2008–2009 had high homology (>97.6%) with other NA1 strains
detected in different parts of the world. NA1 strains detected in
2011–2012, except TTa-11-0405, and two  strains in 2010 (TTa-
10-0261 and TTa-10-0328) were appeared to form a unique
cluster under NA1. Three amino acid substitutions, Asp237, Leu274,
and Ser292 have been previously reported as speciﬁc amino acid
substitutions for NA1.24,25 We also found these substitutions in
most of the NA1 strains analyzed in the present study such as Asp237in 94.2% (82/96), Leu274 in 94.2% (82/96), and Ser292 in 100% (96/96)
(Fig. 4A). Another speciﬁc substitution for NA1, an early stop codon
at position 298, was also observed in 100% (96/96) of NA1 strains.
In addition to these previously reported NA1 speciﬁc substitutions,
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Table 1
Primers used for detection and analysis for human respiratory syncytial viruses (HRSV) at Eastern Visayas Regional Medical Center (EVRMC) from 2008 to 2012.
Primer Sequence (5′ → 3′) Target gene Reference
Multiplex PCR vrs P1 GGAACAAGTTGTTGAGGTTTATGAATATGC Nucleocapsid gene 26
vrs  P2 TTCTGCTGTCAAGTCTAGTACACTGTAGT
vrs i GGTGTACCTCTGTACTCTC
Detection of HRSV 22K1 ATGTCACGAAGGAATCCTTGC M2 gene 27
22K2  TAGCTCTTCATTGTCCCTCAGC
22K3 GAGGTCATTGCTTAAATGG
22K4 GCAACACATGCTGATTGT
Genotyping of HRSV GPA GAAGTGTTCAACTTTGTACC G gene 19
GPB AAGATGATTACCATTTTGAAGT
CCAA
CTCT
TTTGC
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fnRSAG TATGCAGCAACAAT
nRSBG GTGGCAACAATCAA
F1 CAACTCCATTGTTA
wo additional amino acid substitutions, Ile253 and Tyr273 were also
ound in a unique cluster for the strains of 2011 and 2012.
The phylogenetic tree based on the same region for HRSV-
 (330 nucleotides) indicated that all 77 HRSV-B strains were
lassiﬁed as BA, whose genotype could be further divided into
1 branches (Fig. 2B)21,30, however the length of the sequences
eposited in Genbank is too short that those BA11 strains were
xcluded from the analysis. There were only 3 analyzed strains of
RSV-B in 2008, which shared same node with BA10, but they were
ot classiﬁed into any of known BA1 to 11 deposited in Genbank
Fig. 2B). p-distances in between 2008 strains and BA branches were
.038 ± 0.009, which suggesting that this is a new variant.31 These
trains had common sequence for BA7 to BA10 (Pro223), and showed
igh homology with both BA7 and BA10 (98% and 97%, respectively)
ut not with speciﬁc sequence for BA10 (Gly292)21 (Fig. 4B). Further-
ore, they had common amino acid substitution (Gly251), which
ad not been observed in BA7–BA10. From the above ﬁndings, we
onsidered that those 2008 strains variants were diverged from
A10, and we tentatively named these variants as Cluster-A.
On the other hand, most of the strains detected from 2009 to
011 were classiﬁed as BA9, and they had high homology (>97%)
ith other BA9 strains. Additionally, we also found speciﬁc substi-
ution in most of the strains as previously reported, Ala271 in BA9
94.3%, 66/70) (Fig. 4B)20. Interestingly, there were a total of 14
trains detected from July to December 2011, which appeared to
e diverged from BA9. There were no sequences in Genbank which
howed high homology (over 97%). p-distances between them and
ig. 1. Monthly distribution of numbers of hospitalized cases with pneumonia (white ba
uman  respiratory syncytial virus subgroup A (HRSV-A, lattice pattern) and subgroup B (H
rom  2008 to 2012. 21
GC
C
BA branches were 0.072 ± 0.01, suggesting a new variant.31 We  ten-
tatively name this variant as Cluster-B (Figs. 2B and 4B).  Moreover,
Cluster-B had the common node with sharing 3 common unique
amino acid substitutions (Pro219, Lys242, Pro257) (Fig. 4B), and
strains of this branch had same amino acid substitution (Ala271),
which was speciﬁc for BA9. Both clusters did not include strains
which were reported in recent studies.
5. Discussion
In this study, HRSV was detected from 19.3% children who
were hospitalized with severe pneumonia. The results conﬁrmed
the etiological importance of HRSV in hospitalized children with
ALRI in the Philippines,4–6,12,13 but the positive rates of HRSV in
the present study were varied yearly during the study period,
ranging from 33.3% in 2008 to 1.8% in 2009. The detection rate
may ﬂuctuate25 or constant18,31 depending on the study setting.
Since the global dissemination of the pandemic A(H1N1)2009
occurred during the study period, the virus interference by pan-
demic A(H1N1)2009 might have an effect on the incidence of
respiratory viruses including HRSV as observed in China.32 How-
ever, in this study population, pandemic A(H1N1)2009 did not
cause widespread outbreak in 2009. At least none of our study sub-
jects were positive for inﬂuenza A(H1N1)pdm in 2009 (data not
shown). Therefore, it is less likely that epidemic of HRSV in 2009
was interfered by pandemic A(H1N1)2009.
r) and human respiratory syncytial virus (HRSV) positive cases (black bar)(A), and
RSV-B, slanted line) cases (B) at Eastern Visayas Regional Medical Center (EVRMC)
62 A. Ohno et al. / Journal of Clinical Virology 57 (2013) 59– 65
Fig. 2. Phylogenetic tree of human respiratory syncytial virus (HRSV) subgroup A (A) and subgroup B (B) detected in the Philippines from 2008 to 2012. Phylogenetic tree for
subgroups A and B was  constructed based on nucleotide sequence of the secondary hypervariable region of G gene using the neighbor-joining method with MEGA, version
5.  Bootstrap value determined for 1000 interactions. Strains detected in 2008: blue, strains detected in 2009: green, strains detected in 2010: red, strains detected in 2011:
o : Braz
S : Ken
t
e
grange, Strains detected in 2012: purple. BA: Argentina, BKK: Thailand, BR, Bra, RP
pain,  PN, DEL, New Delhi. Dibrugarh.IND: India, Ger: Germany, JPN, NG: Japan, KenThe genotyping of HRSV is important not only for classiﬁca-
ion of the viruses, but also for better understanding its molecular
volution and diversity. The second hypervariable region of G
ene contains strain-speciﬁc epitopes and plays important rolesil, Beijing, Chongqing, Jiangxi: China, mon: Uruguay, MO,  CH, TX, WI:  USA, MAD:
ya, LV: Latvia, US: USA, SAfrica: South Africa.in immune response. Furthermore, recent studies have reported
that emergence of a variant may  intensify the size of outbreak.24
Therefore, monitoring of circulating genotypes of HRSV is impera-
tive.
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ytial v
o
i
s
s
t
F
I
g
HFig. 3. Monthly distribution of human respiratory sync
Different patterns of predominance of HRSV-A and B were
bserved in different parts of the world. For example, the predom-
nant group was changed in 2-year cycle in Finland,33 but another
tudy indicated that both HRSV-A and B were co-circulating in the
ame community.34 NA1, the only genotype for HRSV-A found in
he present study, was ﬁrst identiﬁed in Niigata, Japan in 2004.24
ig. 4. Alignment of amino acid sequence for the secondary hypervariable region of hu
dentical residues are indicated by dots, and stop codons are indicated by asterisks. No am
ray  shows common amino acid in NA1 or BA7-BA10 or BA9, and gray shows common am
RSV-B  (110 amino acids).irus (HRSV) genotypes for HRSV-A (A) and HRSV-B (B).
Recently published data from Cambodia, Korea and China indi-
cated that a majority of HRSV-A viruses detected after 2006 were
NA1.25,35,36 These data together with our present ﬁndings suggest
that NA1 has been predominantly circulating HRSV-A genotype at
least in Asia between 2006 and 2012. Two  strains in 2010 and all
strains in 2012 (except one) formed a unique cluster under NA1,
man respiratory syncytial virus (HRSV) subgroup A (A) and HRSV subgroup B (B).
ino acids are indicated by hyphen inside of duplicated 20 amino acid regions. Light
ino acid in 2011 strain of HRSV-A (90 amino acids) and Cluster-A and Cluster-B of
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hich was branched from strain in 2008 and 2009 and had two
mino acid substitutions speciﬁc to this sub-clade. These ﬁndings
uggest that further molecular evolution has been undergoing for
A1 in the Philippines.
All of HRSV-B strains analyzed were classiﬁed as BA, which was
rst identiﬁed in Buenos Aires, Argentina in 1999. It has a duplica-
ion of 60 nucleotides in the second hypervariable region of the G
ene.19 After its emergence in 1999, BA was spreading globally and
ecame the predominant among the recently circulating HRSV-B
trains in most of the countries.30,37 During the global spread of BA,
iruses had been evolving rapidly and created many new branches
at least 11 branches) under BA.21,30,35 Among these BA branches,
A4 became a dominant branch after 2005.30 However in our study,
A9 was a dominant BA branch from the end of 2009. BA9 was
rst identiﬁed during 2006-2007 season and became a predomi-
ant branch of BA during 2009–2010 season in Niigata, Japan.21 BA9
as also the most common branch of BA in Korea between 2008
nd 2010.35 These ﬁndings indicate that BA9 has become a pre-
ominant BA branch at least in Asia by replacing other BA branches
uch as BA4 and BA5.
Owing to the viral evolution, there is a need to deﬁne recent
lobal distribution of BA variants. We  found potential variants
nder BA, which we tentatively named as Cluster-A and Cluster-
 (Figs. 2B and 4B). Despite of our four years of observation
eriod, Cluster-A strains were detected only in 2008. Given that
hey shared common sequences with BA7–BA10, having speciﬁc
equence, and sharing same node with BA10, they can possibly be
 variant of BA10 branches.
In addition, we detected possible variant under BA9, which
amed as Cluster-B (Figs. 2B and 4B).  Cluster-B was ﬁrst iden-
iﬁed in July 2011, and co-circulating with BA9 until the end of
011. Cluster-B had speciﬁc amino acids substitution for BA9 and 3
nique amino acid substitutions. Therefore, we considered Cluster-
 as a variant under BA9. Further follow up is required to observe
he impact of emergence of these variants.
It was reported that multiple genotypes in each subgroup were
o-circulating.17,38 However, we observed quite simple genotype
istributions in the present study. For HRSV-A, only single geno-
ype, NA1 was found during the study period. BA9 was  the single
ranch found in 2008 as well as from December 2009 and January
011. Only a mixture of branches of BA, i.e. BA9 and Cluster-B was
ound in a cluster of cases in 2011. Our study site hospital, EVRMC is
ocated in Leyte Island, which is a remote island in the Philippines.
uch a geographic isolation may  contribute to distribution of HRSV
ubgroups and genotypes. Further studies are therefore needed to
eﬁne the subgroup and genotype distribution in rural settings in
eveloping countries, where the impact of HRSV may  be high.13,39
There are several limitations in our study. Firstly, we  could not
equence all identiﬁed HRSV strains, which might be worthwhile
o identify other genotypes, if any. Secondly, we conducted this
tudy in one tertiary hospital in an island of the Philippines. Other
laces of the Philippines may  have different distribution patterns
f HRSV subgroup and/or genotype. Thirdly, even though we  cov-
red the last four years in our study, it may  not be enough to draw
ny conclusion on the temporal distributions of subgroup and/or
enotypes of HRSV in this region. Despite these limitations, this is
he ﬁrst molecular analysis on HRSV in the Philippines and our cur-
ent study data contributes to understanding the global scenario of
RSV molecular epidemiology.
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